Study S001801

Glucagon-like Peptide-1 Receptor (GLP-1R) Analogue Assisted Rapid Weight Loss Program as Treatment of Idiopathic Intracranial Hypertension

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06027567
Acronym: IIH:DUAL
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 38
Start: 2022-09-02
Primary completion: 2025-01-28
Lead sponsor: Rigmor Højland Jensen
Conditions: Idiopathic Intracranial Hypertension; Intracranial Pressure; Obesity; Pseudotumor Cerebri Syndrome; Papilledema; Weight Loss
Interventions: DRUG:Semaglutide; DIETARY_SUPPLEMENT:Very Low Calorie Diet; BEHAVIORAL:Dietician counselling
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Weight [8 weeks]
Intracranial pressure [8 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.